228760.KQ

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Biotechnology

Analyst estimates (consensus)

Year	Est. revenue	Growth	Est. EPS	EPS range	Fwd P/E	# Analysts
2026	$7.8B	-77.1%	$-145.00	$-145.00–$-145.00	—	1

Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
228760.KQGenomictree Inc.	$10130.00	+0.50%	$248.5B	—
005250.KSGC Corp.	$9650.00	-0.31%	$434.0B	—
005257.KSGC Corp.	$17890.00	+2.23%	$537.7B	—
053030.KQBINEX Co., Ltd.	$6380.00	-1.09%	$203.2B	—
064550.KQBioneer Corporation	$9860.00	+3.79%	$254.5B	—
078160.KQMEDIPOST Co., Ltd.	$8700.00	+0.00%	$340.0B	—
084990.KQHelixmith Co., Ltd	$2935.00	+0.51%	$135.1B	—

Source: Financial Modeling Prep · peers by sector/industry

Genomictree Inc.

Genomictree Inc. is a molecular diagnostics firm that harnesses biomarkers to develop and market advanced detection tools for both oncological conditions and various infectious diseases. Its product line includes EarlyTect C, a screening solution for the early identification of colorectal cancer. For lung cancer, it offers EarlyTect L, which targets epigenetic markers in patients with pulmonary nodules, and for bladder cancer, EarlyTect B, designed to detect specific genetic and epigenetic markers in individuals with hematuria. The company also provides a range of companion diagnostics: AccuraTect-KRAS and AccuraTect-BRAF assist in colorectal cancer management, while AccuraTect-EGFR supports lung cancer treatment. In addition, Genomictree supplies AccuraDTect SARS-CoV-2 RT-qPCR kits for infectious disease testing, and offers its technologies to support various diagnostic test providers. Founded in 2000, the company is based in Daejeon, South Korea.

www.genomictree.com

Employees: 76
IPO / List date: Jul 19, 2016
HQ: KR

Held by traders on TradeandTell

No one on the platform currently holds 228760.KQ.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in 228760.KQ as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded 228760.KQ yet.